dacarbazine has been researched along with Leukemia, Megakaryocytic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonmassar, E; Caravita, T; D'Atri, S; Franchi, A; Graziani, G; Papa, G; Piccioni, D | 1 |
1 trial(s) available for dacarbazine and Leukemia, Megakaryocytic
Article | Year |
---|---|
Cisplatin increases sensitivity of human leukemic blasts to triazene compounds.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; In Vitro Techniques; Leukemia; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Methyltransferases; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Pilot Projects; Remission Induction; Temozolomide; Treatment Outcome; Triazenes | 1995 |